Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-05-04

Clinical Trial Update: Itopride in Functional Dyspepsia:a Dose Finding Study [Phase 2, Phase 3]

View source ↗

Summary

This report notes a dose-finding trial of Itopride for functional dyspepsia was completed in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ganaton (Itopride)

Snippet

Sponsor: Royal Adelaide Hospital | Conditions: Functional Dyspepsia | Phase 2, Phase 3 | Status: COMPLETED